Showing results (191-200 of 234) with videos related to
Sort By:
Pageof 24
Neurological Research|January 23, 2013
Deep venous thrombosis and pulmonary embolisms in adult patients undergoing craniotomy for brain tumorsKaisorn L Chaichana, Courtney Pendleton, Christopher Jackson, et al.Journal of Neuro-Oncology|October 16, 2025
Stereotactic radiosurgery for patients with extensive brain metastases across the disease courseTina Vaziri, I-Chia Liu, Chetan Bettegowda, et al.Biomaterials|February 26, 2019
Nanoparticle-mediated intratumoral inhibition of miR-21 for improved survival in glioblastomaYoung-Eun Seo, Hee-Won Suh, Raman Bahal, et al.Neurosurgery|July 25, 2022
Predictors and Impact of Postoperative 30-Day Readmission in GlioblastomaDavid Botros, Adham M Khalafallah, Sakibul Huq, et al.Journal of Neuro-Oncology|January 29, 2021
Development of new brain metastases in triple negative breast cancerRavi Medikonda, Siddhartha Srivastava, Timothy Kim, et al.Clinical Proteomics|February 5, 2025
The effect of storage time and temperature on the proteomic analysis of FFPE tissue sectionsJennifer M S Koh, Erin K Sykes, Jyoti Rukhaya, et al.Clinical Colorectal Cancer|July 24, 2018
Effect of Primary Tumor Side on Survival Outcomes in Untreated Patients With Metastatic Colorectal Cancer When Selective Internal Radiation Therapy Is Added to Chemotherapy: Combined Analysis of Two Randomized Controlled StudiesPeter Gibbs, Volker Heinemann, Navesh K Sharma, et al.Journal of Neuro-Oncology|January 3, 2025
Creating a predictive model and online calculator for high-value care outcomes following glioblastoma resection: incorporating neighborhood socioeconomic status indexFoad Kazemi, Julian L Gendreau, Megan Parker, et al.Cancer Chemotherapy and Pharmacology|August 18, 2025
A thymine-challenge test to prospectively evaluate dihydropyrimidine dehydrogenase activity for risk of severe 5-fluorouracil-induced gastrointestinal toxicityNuala Helsby, Katrina Sharples, Yu Jin Kim, et al.Frontiers in Immunology|October 17, 2022
Innate immune checkpoint inhibitor resistance is associated with melanoma sub-types exhibiting invasive and de-differentiated gene expression signaturesSultana Mehbuba Hossain, Gregory Gimenez, Peter A Stockwell, et al.Pageof 24